The CDC Yellow Book has been a trusted resource among healthcare professionals.
Follow Us On
This research addresses the mental health of family carers of adults with learning disabilities. We...
Accessible occupational health advice is only available to approximately half the United Kingdom...
Providing patient-centered care requires involving patients in their personal health care decisions...
The CDC Yellow Book has been a trusted resource among healthcare professionals for over half a...
The policy community, international and national, recognizes the significant health and economic impacts of antimicrobial resistance (AMR) on...
Cardiovascular disease has declined but remains a major disease burden across developed countries. ...
The objective of this Technical Brief is to assess the current use of life cycle assessment (LCA) frameworks in healthcare...
CADTH recommends that Olumiant be reimbursed by public drug plans for the treatment of adults with severe alopecia areata (AA)...
This rapid review updates the evidence for early biologic treatment versus conventional step-up therapy for patients with luminal Crohn disease...
This rapid review examines the clinical efficacy, effectiveness, and safety of BRAF and MEK inhibitors as a treatment for patients...
Canada’s Drug Agency recommends that Crysvita be reimbursed by public drug plans for the treatment of X-linked hypophosphatemia (XLH) in...
Vital Statistics Rapid Release Reports are based on the current flow of vital statistics data from state vital records offices...
